phthalimide has been researched along with thalidomide in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brundrette, R; Gordon, G; Hess, AD; Santos, GW; Vogelsang, GB | 1 |
| Baguley, BC; Browne, WL; Ching, LM; Gregory, T; Palmer, BD; Tchernegovski, R | 1 |
| Alves, CC; Amarante, GW; Cardoso, SH; de Almeida, MV; de Souza, MV; Ferreira, AP; Mattos, AM; Teixeira, FM; Teixeira, HC | 1 |
| Abdin, YG; Gamal-Eldeen, AM; Osman, AM; Pedersen, EB; Talaat, RM; Zahran, MA | 1 |
| Bradner, JE; Buckley, DL; Dhe-Paganon, S; Paulk, J; Roberts, JM; Souza, A; Winter, GE | 1 |
| Ambrożak, A; Beedie, SL; Figg, WD; Gardner, ER; Gütschow, M; Schnakenburg, G; Steinebach, C | 1 |
6 other study(ies) available for phthalimide and thalidomide
| Article | Year |
|---|---|
Thalidomide induction of bone marrow transplantation tolerance.
Topics: Aminoglutethimide; Animals; Bone Marrow Transplantation; Female; Fluorescence; Graft vs Host Disease; Immunosuppression Therapy; Phthalimides; Rats; Rats, Inbred ACI; Rats, Inbred BN; Rats, Inbred Lew; Rats, Inbred WF; T-Lymphocytes; Thalidomide | 1987 |
Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity.
Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Drug Synergism; Mice; Neoplasm Transplantation; Pentoxifylline; Phthalimides; Thalidomide; Time Factors; Tumor Necrosis Factor-alpha; Xanthenes; Xanthones | 1998 |
Thalidomide analogs from diamines: Synthesis and evaluation as inhibitors of TNF-alpha production.
Topics: Angiogenesis Inhibitors; Diamines; Immunosuppressive Agents; Leprostatic Agents; Phthalic Anhydrides; Phthalimides; Stereoisomerism; Structure-Activity Relationship; Thalidomide; Tumor Necrosis Factor-alpha | 2007 |
Synthesis and evaluation of thalidomide and phthalimide esters as antitumor agents.
Topics: Animals; Antineoplastic Agents; Cell Survival; Esters; Hep G2 Cells; Humans; Macrophages; MCF-7 Cells; Mice; Molecular Structure; Phthalimides; Protein Binding; Receptors, Vascular Endothelial Growth Factor; Structure-Activity Relationship; Thalidomide | 2014 |
DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation.
Topics: Adaptor Proteins, Signal Transducing; Animals; Azepines; Cell Cycle Proteins; Cell Line, Tumor; Crystallography, X-Ray; Disease Models, Animal; Drug Design; Leukemia, Promyelocytic, Acute; Ligands; Mice; Molecular Targeted Therapy; Nuclear Proteins; Peptide Hydrolases; Phthalimides; Protein Stability; Protein Structure, Tertiary; Proteolysis; Tacrolimus Binding Protein 1A; Thalidomide; Transcription Factors; Ubiquitin-Protein Ligases | 2015 |
Synthesis and Antiangiogenic Properties of Tetrafluorophthalimido and Tetrafluorobenzamido Barbituric Acids.
Topics: Angiogenesis Inhibitors; Animals; Aorta; Barbiturates; Crystallography, X-Ray; Molecular Conformation; Phthalimides; Rats; Structure-Activity Relationship; Thalidomide | 2016 |